Literature DB >> 26781380

Sporothrix chilensis sp. nov. (Ascomycota: Ophiostomatales), a soil-borne agent of human sporotrichosis with mild-pathogenic potential to mammals.

Anderson Messias Rodrigues1, Rodrigo Cruz Choappa2, Geisa Ferreira Fernandes3, G Sybren de Hoog4, Zoilo Pires de Camargo3.   

Abstract

A combination of phylogeny, evolution, morphologies and ecologies has enabled major advances in understanding the taxonomy of Sporothrix species, including members exhibiting distinct lifestyles such as saprobes, human/animal pathogens, and insect symbionts. Phylogenetic analyses of ITS1/2 + 5.8s sequences split Sporothrix genus in two well-defined groups with dissimilar ecologies. Species embedded in the Sporothrix schenckii complex are frequently agents of human and animal sporotrichosis, and some of these are responsible for large sapronoses and zoonoses around the warmer temperate regions of the world. At the other extreme, basal saprophytic species evolved in association with decaying wood and soil, and are rarely found to cause human disease. We propose to create a new taxa, Sporothrix chilensis sp. nov., to accommodate strains collected from a clinical case of onychomycosis as well as from environmental origins in Chile. Multigene analyses based on ITS1/2 + 5.8s region, beta-tubulin, calmodulin and translation elongation factor 1α revealed that S. chilensis is a member of the Sporothrix pallida complex, and the nearest taxon is Sporothrix mexicana, a rare soil-borne species, non-pathogenic to humans. The ITS region serves as a primary barcode marker, while each one of the protein-coding loci easily recognized species boundaries providing sufficient information for species identification. A disseminated model of murine sporotrichosis revealed a mild-pathogenic potential, with lung invasion. Although S. chilensis is not a primary pathogen, accidental infection may have an impact in the immunosuppressed population. With the introduction of distinct species with similar routes of transmission but different virulence, identification of Sporothrix agents at the species level is mandatory.
Copyright © 2015 The British Mycological Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Barcoding; Cryptic species; Phylogeny; Taxonomy; Virulence

Mesh:

Year:  2015        PMID: 26781380     DOI: 10.1016/j.funbio.2015.05.006

Source DB:  PubMed          Journal:  Fungal Biol


  38 in total

1.  The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection.

Authors:  Amanda Costa Gonçalves; Lucas Souza Ferreira; Francine Alessandra Manente; Carolina Maria Quinello Gomes de Faria; Marisa Campos Polesi; Cleverton Roberto de Andrade; Dario Simões Zamboni; Iracilda Zeppone Carlos
Journal:  Immunology       Date:  2017-03-03       Impact factor: 7.397

Review 2.  Name Changes for Fungi of Medical Importance, 2016-2017.

Authors:  David W Warnock
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

3.  Evolution of virulence-related phenotypes of Sporothrix brasiliensis isolates from patients with chronic sporotrichosis and acquired immunodeficiency syndrome.

Authors:  Ingrid Ludmila Rodrigues Cruz; Dayvison Francis Saraiva Freitas; Priscila Marques de Macedo; Maria Clara Gutierrez-Galhardo; Antonio Carlos Francesconi do Valle; Marcos de Abreu Almeida; Rowena Alves Coelho; Fábio Brito-Santos; Maria Helena Galdino Figueiredo-Carvalho; Rosely Maria Zancopé-Oliveira; Rodrigo Almeida-Paes
Journal:  Braz J Microbiol       Date:  2020-05-22       Impact factor: 2.476

Review 4.  Fungal infections in animals: a patchwork of different situations.

Authors:  Seyedmojtaba Seyedmousavi; Sandra de M G Bosco; Sybren de Hoog; Frank Ebel; Daniel Elad; Renata R Gomes; Ilse D Jacobsen; Henrik Elvang Jensen; An Martel; Bernard Mignon; Frank Pasmans; Elena Piecková; Anderson Messias Rodrigues; Karuna Singh; Vania A Vicente; Gudrun Wibbelt; Nathan P Wiederhold; Jacques Guillot
Journal:  Med Mycol       Date:  2018-04-01       Impact factor: 4.076

5.  Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.

Authors:  Jéssica Sepulveda Boechat; Sandro Antonio Pereira; Ana Caroline de Sá Machado; Paula Gonçalves Viana; Rodrigo Almeida-Paes; Rosely Maria Zancopé-Oliveira; Isabella Dib Ferreira Gremião; Manoel Marques Evangelista de Oliveira
Journal:  Braz J Microbiol       Date:  2020-07-02       Impact factor: 2.476

Review 6.  The Historical Burden of Sporotrichosis in Brazil: a Systematic Review of Cases Reported from 1907 to 2020.

Authors:  Vanessa Brito Souza Rabello; Marcos Abreu Almeida; Andrea Reis Bernardes-Engemann; Rodrigo Almeida-Paes; Priscila Marques de Macedo; Rosely Maria Zancopé-Oliveira
Journal:  Braz J Microbiol       Date:  2021-11-26       Impact factor: 2.476

7.  A Spotlight on Sporothrix and Sporotrichosis.

Authors:  Anderson Messias Rodrigues; Ferry Hagen; Zoilo Pires de Camargo
Journal:  Mycopathologia       Date:  2022-07-01       Impact factor: 3.785

8.  Phenotypic and molecular characterisation of Sporothrix globosa of diverse origin from India.

Authors:  Shivaprakash M Rudramurthy; Shamanth A Shankarnarayan; Basavaraj M Hemashetter; Santwana Verma; Smriti Chauhan; Reema Nath; Jayanthi Savio; Malini Capoor; Harsimran Kaur; Anup K Ghosh; Arunaloke Chakrabarti
Journal:  Braz J Microbiol       Date:  2020-07-30       Impact factor: 2.476

Review 9.  Cavitary Pulmonary Sporotrichosis: Case Report and Literature Review.

Authors:  Florencia D Rojas; Mariana S Fernández; Juan Manuel Lucchelli; Dora Lombardi; José Malet; María Eugenia Vetrisano; María Emilia Cattana; María de Los Ángeles Sosa; Gustavo Giusiano
Journal:  Mycopathologia       Date:  2017-10-23       Impact factor: 2.574

10.  Atypical Clinical Presentation of Sporotrichosis Caused by Sporothrix globosa Resistant to Itraconazole.

Authors:  Olga Fischman Gompertz; Anderson M Rodrigues; Geisa F Fernandes; Henri D L Bentubo; Zoilo Pires de Camargo; Valéria Petri
Journal:  Am J Trop Med Hyg       Date:  2016-04-25       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.